Screening for carbapenemase-producing Enterobacterales (CPE)—considering the practical implications of molecular results, the value of culture and deciding criteria for resistance
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Mairead Skally und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Beaumont Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Enterobacteriaceae Infections, beta-Lactamases, Bacterial Proteins, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Irish Research Council, Employment-Based Postgraduate Programme.
Abstract (Originalsprache)
Background
Carbapenemase-producing Enterobacterales (CPE) are of international concern. Screening for CPE can encompass single- or two-step approaches, using culture, PCR or a combination. Each approach has benefits, but none are without disadvantage.
Objectives
To reflect on the challenges and implications of PCR-positive/culture-negative CPE screening results and assess if PCR cycle threshold (Ct) value can be helpful in predicting positive culture results. Patients and methods Risk factor-based CPE screening swabs were tested using a two-step algorithm: PCR followed by culture of PCR-positive specimens. Data on all PCR-positive specimens between 1 August 2022 and 31 May 2024 were extracted. ORs were estimated using receiver operating characteristic (ROC) curves to compare Ct values and culture. Youden’s index was calculated to establish the optimal Ct cut-off value. Compliance with the CPE screening pathway for newly identified CPE PCR-positive patients was assessed.
Results
Of 61 268 CPE screens, 292 were PCR positive (0.5%), with 298 genes identified. Of these, 81.5% were culture confirmed. ROC analysis showed an AUC of 0.82 and Youden’s index yielding a Ct cut-off value of 33.7. Repeat CPE screens were obtained from 33 new PCR-positive, culture-negative inpatients. Further investigation was not possible for 17 new PCR-positive, culture-negative patients (11%).
Conclusions
Molecular platforms alone cannot detect species or antimicrobial resistance. A molecular-followed-by-culture algorithm can reduce workloads associated with culture, resulting in comprehensive data, including antimicrobial susceptibility results, to support informed clinical, policy and epidemiological decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
- Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.
- Department of Infection Prevention and Control, Beaumont Hospital, Dublin, Ireland.
- Data Science Centre, School of Population Health, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.
ORCID-Profile: Mairead Skally, Fidelma Fitzpatrick
Förderung
- Irish Research Council
- Employment-Based Postgraduate Programme
Zitieren
APA
Skally, M., Cafferkey, J., Russell, M., Mcbrierty, L., Bijoy, R., Burns, K., Bennett, K., Humphreys, H., & Fitzpatrick, F. (2025). Screening for carbapenemase-producing Enterobacterales (CPE)—considering the practical implications of molecular results, the value of culture and deciding criteria for resistance. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf088
Vancouver
Skally M, Cafferkey J, Russell M, Mcbrierty L, Bijoy R, Burns K, et al. Screening for carbapenemase-producing Enterobacterales (CPE)—considering the practical implications of molecular results, the value of culture and deciding criteria for resistance. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf088
BibTeX
@article{Skally2025,
author = {Skally, Mairead and Cafferkey, Jacqueline and Russell, Miriam and Mcbrierty, Lynn and Bijoy, Rincy and Burns, Karen and Bennett, Kathleen and Humphreys, Hilary and Fitzpatrick, Fidelma},
title = {Screening for carbapenemase-producing Enterobacterales (CPE)—considering the practical implications of molecular results, the value of culture and deciding criteria for resistance},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf088}
}
EUVIMED